Related Experiment Video
Updated: Nov 2, 2025

04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.7K
Bosutinib-associated interstitial lung disease and pleural effusion: A case report and literature review
Qiuying Selina Liu1, Nour Ali Ass'ad1, Cecilia Arana Yi1,2
1University of New Mexico School of Medicine Albuquerque NM USA.
Clinical Case Reports
|June 7, 2021
Abstract:
Bosutinib is a tyrosine kinase inhibitor approved for the management of chronic myeloid leukemia (CML). Interstitial lung disease and pleural effusion are pulmonary side effects of TKIs rarely associated with bosutinib treatment.

